The insulin-like growth factor (IGF) axis is a multi-component network
of molecules involved in the regulation of cell growth. The axis incl
udes two major ligands, (IGF-I and IGF-II), cell surface receptors, (t
he type I IGF receptor family as well as the type II IGF receptor), a
family of high affinity binding proteins which regulate IGF availabili
ty to the receptors, (the IGFBPs), and a group of IGFBP proteases whic
h cleave IGFBBPs and modulate IGF action. Human seminal plasma contain
s IGF-I and -II, IGFBP-2 and -4, as well as IGFBP3 fragments and IGFBP
3 protease activity. A prostatic source for these IGF-axis molecules i
s likely. We have demonstrated the human prostate to contain all the e
lements of a functional IGF system. Prostate fibroblasts in primary cu
lture (PC-F) express mRNA for IGF-II and produce IGF-II peptide in bio
logically active concentrations. This TGF-II appears to be of a high m
olecular weight (15kD) species. Prostate epithelial cells in primary c
ulture (PC-E) express the type I IGF receptor. These cells also produc
e IGFBP-2 and -4, (on both mRNA and peptide levels), while PC-F secret
e IGFBP-2,-3 and -4. PC-E are exquisitely sensitive to the mitogenic e
ffects of IGFs. Finally, prostate specific antigen (PSA), secreted fro
m PC- and found in seminal plasma, can function as a potent IGFBP3 pro
tease. This IGFBP3 protease activity can remove the inhibitory effects
of IGFBP3 on IGF-I induced PC-3 growth. We have recently shown that P
C-F from patients with benign prostatic hypertrophy (BPH) hyper-expres
s mRNA for IGF-II. This observation and other related findings suggest
a regression of these fibroblasts to a state reminiscent of fetal fib
roblasts. This molecular alteration in a critical component of the pro
static IGF axis in BPH patients may also be involved in the pathogenes
is of abnormal prostate epithelial proliferation.